Allergan, Argentum settle patent dispute over eye drug Restasis

(Reuters) - U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, Restasis.

Source: Reuters: Health - April 18, 2017 Category: Consumer Health News Tags: healthNews Source Type: news